Ticker Details
Fulgent Genetics, Inc. Fulgent Genetics Inc is a technology company offering genetic testing to provide physicians with clinically actionable diagnostic information used to improve the overall quality of patient care.
IPO Date:	September 29, 2016
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$485.93M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.88 | 2.84%
Avg Daily Range (30 D):	$0.33 | 2.15%
Avg Daily Range (90 D):	$0.37 | 2.07%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.45M
Avg Daily Volume (90 D):	.44M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	49

Institutional Trades
Total Institutional Trades:	1,933
Avg Institutional Trade:	$1.76M
Avg Institutional Trade (30 D):	$.95M
Avg Institutional Trade (90 D):	$1.1M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.84M
Avg Closing Trade (30 D):	$.92M
Avg Closing Trade (90 D):	$1.06M
Avg Closing Volume:	45.68K

News

Apr 17, 2026 @ 7:20 PM Lowey Dannenberg, P.C. is Investigating Fulgent Ge... Source: Lowey Dannenberg P.C.

Mar 20, 2026 @ 12:00 AM FLGT SHAREHOLDER ALERT: Investors Encouraged to Co... Source: Kirby Mcinerney Llp

Jan 30, 2026 @ 9:57 AM Esoteric Testing Research Report 2026 - Global $41... Source: Researchandmarkets.Com

Aug 1, 2025 @ 8:26 PM Why Fulgent Genetics Stock Was Crushing It on Frid... Source: Eric Volkman

Jul 15, 2025 @ 11:41 PM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS
Diluted EPS
Revenue	$320.35M	$71.14M	$83.34M
Gross Profit	$124.02M	$21.49M	$32.58M
Net Income / Loss	$-75.01M	$-25.27M	$-23.65M
Operating Income / Loss	$-105.92M	$-34.62M	$-36.24M
Cost of Revenue	$196.33M	$49.65M	$50.75M
Net Cash Flow	$-43.88M	$-26.79M	$-67.45M
PE Ratio